WallStSmart

Eltek Ltd (ELTK)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 400% more annual revenue ($258.90M vs $51.79M). ELTK leads profitability with a 1.6% profit margin vs -15.5%. ELTK earns a higher WallStSmart Score of 46/100 (D+).

ELTK

Hold

46

out of 100

Grade: D+

Growth: 5.3Profit: 4.0Value: 5.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ELTKFair Value (-1.2%)

Margin of Safety

-1.2%

Fair Value

$8.51

Current Price

$8.80

$0.29 premium

UndervaluedFair: $8.51Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ELTK3 strengths · Avg: 9.3/10
PEG RatioValuation
0.2210/10

Growing faster than its price suggests

Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
23.1%8/10

Revenue surging 23.1% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

ELTK4 concerns · Avg: 3.0/10
Market CapQuality
$58.40M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
1.9%3/10

ROE of 1.9% — below average capital efficiency

Profit MarginProfitability
1.6%3/10

1.6% margin — thin

Operating MarginProfitability
0.9%3/10

Operating margin of 0.9%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : ELTK

The strongest argument for ELTK centers on PEG Ratio, Price/Book, Revenue Growth. Revenue growth of 23.1% demonstrates continued momentum. PEG of 0.22 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : ELTK

The primary concerns for ELTK are Market Cap, Return on Equity, Profit Margin. A P/E of 72.4x leaves little room for execution misses. Thin 1.6% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ELTK profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ELTK scores higher overall (46/100 vs 41/100) and 23.1% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Eltek Ltd

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Eltek Ltd. manufactures, markets and sells printed circuit boards (PCBs) in Israel, Europe, North America, India, the Netherlands and internationally. The company is headquartered in Petach Tikva, Israel.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?